Skip to content

Trial of Computerized MET for Adolescent Substance Use

Randomized Controlled Trial of Computerized MET for Adolescent Substance Use

Status
Withdrawn
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01784653
Enrollment
0
Registered
2013-02-06
Start date
2013-10-31
Completion date
Unknown
Last updated
2017-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Abuse, Alcohol Abuse, Nicotine Dependence

Keywords

Substance abuse, Drug abuse, Alcohol abuse, Tobacco, Adolescent

Brief summary

The purpose of this study is to test the effects of a computerized, self-directed Motivational Enhancement Therapy program for adolescent substance use (iMET), in comparison to clinician-delivered MET and Treatment As Usual (TAU), on treatment engagement and substance use. The investigators hypothesize that both iMET and MET will be more effective than TAU in engaging/retaining patients in treatment and in reducing substance use during a 12-month follow-up period. The investigators also hypothesize that Self-directed iMET will be as effective as the clinician-guided MET in increasing treatment engagement and abstinence during the 12-months follow-up period.

Interventions

BEHAVIORALiMET

Self-completed, computerized motivational enhancement therapy

BEHAVIORALMET

Clinician-delivered Motivational Enhancement Therapy

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* completed initial visit at the treatment program; * be available to return for iMET/MET sessions (if assigned) * be available to complete all follow-up measurements * a past-12-month CRAFFT score \>1 * have used substances on \>6 days (not including tobacco use) during the 90 days preceding their visit

Exclusion criteria

* unable to speak and understand English, or read English at a 5th grade reading level * youth deemed by the clinical team to require immediate hospitalization or referral to more intensive residential treatment

Design outcomes

Primary

MeasureTime frameDescription
Treatment engagement12 monthsWe will compare the number of individual visits in the program, the number of group sessions completed, and the number of urine screens completed during a 12 month follow-up period by each participant in the three study arms.

Secondary

MeasureTime frameDescription
Days abstinentpast-90-daysWe will calculate the past-90-days number of days abstinent from any substance use and from the primary substance and the number of weeks abstinent from any substance use.
Driving/Riding Riskpast-90-daysWe will compare group trends in prevalence and frequency of past-90-days Driving while impaired or Riding with an impaired driver.
HIV Risk Behaviorpast-90-daysWe will compare group trends in prevalence and frequency of past-90-days HIV Risk Behaviors.

Other

MeasureTime frameDescription
Treatment process/quality60 daysWe will compare completion of the 2 MET sessions, and completion of the third follow-up visit between the iMET and MET conditions.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026